Moreover, immune checkpoint molecules such as PD-1, PD-L1, PD-L2, and CTLA4, which are involved in immune evasion from CD8+ T cells, are overexpressed in CD34+ cells and PBMCs derived from MDS patients. This evidence concerns the gene CD8A and myelodysplastic syndrome.